Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Colin D. Weekes, M.D., Ph.D.

Concepts (292)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms34202352132.190 Why?
Deoxycytidine920208251.300 Why?
Adenocarcinoma14202363181.080 Why?
Neuropilin-132014910.960 Why?
Antineoplastic Combined Chemotherapy Protocols242023114100.870 Why?
Paclitaxel5202317010.850 Why?
Carcinoma, Pancreatic Ductal9202216070.820 Why?
Albumins420235630.790 Why?
Immunoglobulin Fc Fragments120202790.640 Why?
Neoplasms152022215070.630 Why?
Diphenylamine22017500.600 Why?
Fluorouracil7202216090.570 Why?
Phenylurea Compounds220195240.570 Why?
Maximum Tolerated Dose920208880.570 Why?
Immunoconjugates320218890.560 Why?
GPI-Linked Proteins220204330.540 Why?
Sirolimus2201315590.520 Why?
Quinolines120187210.440 Why?
Gastrointestinal Neoplasms420239810.440 Why?
Receptors, G-Protein-Coupled1202012140.440 Why?
Recombinant Fusion Proteins1202037700.400 Why?
Camptothecin220215700.390 Why?
Mitogen-Activated Protein Kinase 1120134890.390 Why?
Antibodies, Monoclonal4201892590.370 Why?
Thymidylate Synthase12010740.370 Why?
Chemokine CXCL12120124620.370 Why?
Antineoplastic Agents92020136350.350 Why?
Liver Neoplasms4202142160.350 Why?
Protein Kinase Inhibitors6202055020.350 Why?
Pyridines2201928100.350 Why?
Neoadjuvant Therapy8202226880.340 Why?
Angiogenesis Inhibitors3201420370.340 Why?
Antineoplastic Agents, Phytogenic120136230.340 Why?
Carcinoma, Hepatocellular2201821850.310 Why?
Xenograft Model Antitumor Assays2201335620.310 Why?
Sulfonamides2201719340.300 Why?
Receptors, CXCR4120127260.300 Why?
Drug Resistance, Neoplasm4201951480.300 Why?
Neoplasm Staging112021109610.290 Why?
Biliary Tract Neoplasms220181770.260 Why?
Molecular Targeted Therapy1201627270.240 Why?
Aged3720231626980.240 Why?
Neoplasm, Residual220219700.230 Why?
Enhancer Elements, Genetic1201013300.230 Why?
Middle Aged4020222128630.230 Why?
TOR Serine-Threonine Kinases1201221020.220 Why?
Hypoalbuminemia12023860.210 Why?
Benzimidazoles220188490.210 Why?
Colorectal Neoplasms4202467260.210 Why?
Drug Administration Schedule5202149350.210 Why?
Rectal Neoplasms2202111920.200 Why?
Adult3120222133940.200 Why?
Coronary Vasospasm12022880.200 Why?
Humans7320247393980.200 Why?
Colonic Neoplasms1201325300.190 Why?
Indolizines12020370.190 Why?
Receptors, Lymphocyte Homing120011430.190 Why?
Cyclic N-Oxides12020780.190 Why?
Lymphoma2200118730.190 Why?
Treatment Outcome172021626930.190 Why?
Pyridinium Compounds12020840.190 Why?
Mice, Nude4201736920.180 Why?
Immunosuppressive Agents1201341430.180 Why?
Piperidines2202015970.180 Why?
Female4420233788530.180 Why?
Leucovorin420226180.180 Why?
Aged, 80 and over162022576500.170 Why?
Male4120233490220.170 Why?
Azetidines120201420.170 Why?
Ovarian Neoplasms1201648150.170 Why?
Neoplasm Transplantation2201320840.160 Why?
Quinazolinones120202230.160 Why?
Heterocyclic Compounds, 3-Ring120202170.160 Why?
Integrin alpha5beta112018380.160 Why?
Administration, Oral4202039090.160 Why?
Stromal Cells2200113500.160 Why?
Dose-Response Relationship, Drug52018109450.150 Why?
Pyrrolidinones120181190.150 Why?
Quinazolines2201513560.150 Why?
Losartan120192840.150 Why?
Pancreas3202016780.150 Why?
Mitogen-Activated Protein Kinase Kinases120206480.150 Why?
MAP Kinase Kinase 212017970.150 Why?
Purines120205930.140 Why?
Integrins120018450.140 Why?
Wnt Proteins120207190.140 Why?
Peritoneal Neoplasms120226630.140 Why?
Antigens, Surface1202016670.130 Why?
Phosphatidylinositol 3-Kinases3202029330.130 Why?
Bone Marrow Purging119951090.130 Why?
Vaccines120248020.130 Why?
MAP Kinase Kinase 1120173380.130 Why?
Tumor Microenvironment2202135080.130 Why?
Ferrosoferric Oxide120163640.120 Why?
Drug Interactions1201914560.120 Why?
Transplantation, Heterologous2201323810.120 Why?
Platinum120162290.120 Why?
Retreatment120166030.120 Why?
Sulfones220144360.120 Why?
DNA, Neoplasm1201917540.120 Why?
Hodgkin Disease1200214130.120 Why?
Social Environment1201910140.120 Why?
Hypoxia-Inducible Factor 1, alpha Subunit120176280.110 Why?
Glycine220146740.110 Why?
Antimetabolites, Antineoplastic120176400.110 Why?
Workplace120198370.110 Why?
MAP Kinase Signaling System1202015220.110 Why?
Mucin-1120175420.110 Why?
Biological Assay120166530.110 Why?
Receptors, CXCR12012530.110 Why?
Pyrazines1201812320.110 Why?
Imidazoles1201812070.100 Why?
ras Proteins2201710620.100 Why?
Proto-Oncogene Proteins p21(ras)2202416740.100 Why?
Radiosurgery1202113050.100 Why?
Chemoembolization, Therapeutic120121280.100 Why?
Quality of Life52023126400.100 Why?
Membrane Transport Proteins1201710280.100 Why?
Proto-Oncogene Proteins B-raf3201920150.100 Why?
Cyclin D1120124620.090 Why?
Insulin-Like Growth Factor I1201820150.090 Why?
Neoplasm Metastasis5202048320.090 Why?
Disease Progression42022132370.090 Why?
Thrombosis1202329610.090 Why?
Young Adult62021562550.080 Why?
Patient Care Team1202025270.080 Why?
Class I Phosphatidylinositol 3-Kinases120138880.080 Why?
Drug Synergism1201317920.080 Why?
Tissue Distribution1201323450.080 Why?
Cell Line, Tumor32017166460.080 Why?
Prognosis62022289010.080 Why?
Carcinoma, Non-Small-Cell Lung2202051540.080 Why?
Bone Marrow1199829330.080 Why?
Positron-Emission Tomography2202263610.080 Why?
Autophagy1201612950.080 Why?
RNA Interference2201728990.080 Why?
Cell Culture Techniques1199516620.080 Why?
High-Throughput Nucleotide Sequencing1202035710.070 Why?
Standard of Care220225630.070 Why?
Proto-Oncogene Proteins c-myc120129840.070 Why?
Drug Design1201210880.070 Why?
Metabolome120138810.070 Why?
Proto-Oncogene Proteins3201445550.070 Why?
Tumor Cells, Cultured3200163100.070 Why?
Retrospective Studies102023766310.070 Why?
Registries1202180390.070 Why?
Energy Metabolism1201728960.070 Why?
Cohort Studies62023403890.060 Why?
Homozygote1201017880.060 Why?
Glucose1201743770.060 Why?
Demography1201016500.060 Why?
Diabetes Mellitus1202357020.060 Why?
Signal Transduction52017233550.060 Why?
Mutation32020296580.060 Why?
Magnetic Resonance Imaging32022353260.060 Why?
Disease-Free Survival3201768710.060 Why?
Mesenteric Veins12023890.060 Why?
RNA, Small Interfering1201234980.060 Why?
Contrast Media1201652930.050 Why?
Fluorodeoxyglucose F182202220260.050 Why?
Chlorambucil12002430.050 Why?
Cell Communication2200116180.050 Why?
Carcinoembryonic Antigen120233470.050 Why?
Procarbazine120021810.050 Why?
Cell Adhesion2201731370.050 Why?
Survival Rate32022127610.050 Why?
Immunohistochemistry12016113470.050 Why?
CA-19-9 Antigen120221100.050 Why?
Chemotherapy, Adjuvant2202034530.050 Why?
Combined Modality Therapy3202286050.050 Why?
Vascular Endothelial Growth Factor A1201235040.050 Why?
Phosphorylation1201284160.050 Why?
Azacitidine120223440.050 Why?
Prednisolone120023320.050 Why?
Portal Vein120234330.050 Why?
Bleomycin120024960.050 Why?
Integrin alpha4beta1120011200.050 Why?
Nitrates120222650.050 Why?
Survival Analysis22012102470.050 Why?
Vinblastine120024880.050 Why?
Genes, MHC Class I120212570.050 Why?
Hematologic Tests120212370.050 Why?
Clinical Trials, Phase I as Topic120213150.040 Why?
Preoperative Period120225460.040 Why?
Microsatellite Repeats120217970.040 Why?
Blood Loss, Surgical120236580.040 Why?
Mice42016810020.040 Why?
Edema120237910.040 Why?
Calcium Channel Blockers120226860.040 Why?
Image Processing, Computer-Assisted1201689770.040 Why?
Cancer Care Facilities120214010.040 Why?
Clinical Trials, Phase II as Topic120216180.040 Why?
Animals720171683680.040 Why?
Plasma Membrane Calcium-Transporting ATPases12017160.040 Why?
Pentose Phosphate Pathway120171250.040 Why?
Tomography, X-Ray Computed22021200550.040 Why?
Monocarboxylic Acid Transporters12017800.040 Why?
Coculture Techniques1200113430.040 Why?
Carcinoma, Renal Cell1201231010.040 Why?
Digoxin120172510.040 Why?
Factor Analysis, Statistical120199760.040 Why?
Biological Specimen Banks120216920.030 Why?
Genetic Heterogeneity120197270.030 Why?
Autopsy1201910040.030 Why?
Antigens, Neoplasm1202419770.030 Why?
Granulocyte-Macrophage Colony-Stimulating Factor120199030.030 Why?
Pancreatectomy120207990.030 Why?
Doxorubicin1200222180.030 Why?
Genotype12010129510.030 Why?
Kidney Neoplasms1201241890.030 Why?
Job Satisfaction120195360.030 Why?
Breast Neoplasms22020206760.030 Why?
Culture120196270.030 Why?
Neoplasm Recurrence, Local2202491220.030 Why?
Radiotherapy, Adjuvant1202017710.030 Why?
Subcutaneous Fat120183920.030 Why?
Immunity1202110080.030 Why?
Radiotherapy1202115260.030 Why?
Proto-Oncogene Proteins c-met120185780.030 Why?
Radiotherapy Dosage1202128720.030 Why?
Follow-Up Studies22013389420.030 Why?
Carbon120176840.030 Why?
Cyclophosphamide1201922380.030 Why?
Muscles1201816080.030 Why?
Organ Size1201822470.030 Why?
Research1202120010.030 Why?
Neoplasm Invasiveness1200136030.030 Why?
Glycosylphosphatidylinositols12012930.030 Why?
Immunologic Factors1202115710.030 Why?
Calcium Signaling120177210.030 Why?
Patient Participation1202114410.030 Why?
Gene Expression Regulation, Enzymologic1201712130.030 Why?
Prospective Studies32021530370.030 Why?
Radiopharmaceuticals1202226870.030 Why?
Peptides1202443950.030 Why?
Feasibility Studies1202150580.020 Why?
Cell Cycle Proteins2201434330.020 Why?
Phosphatidylinositol 3-Kinase120121290.020 Why?
Tumor Burden1201719040.020 Why?
Radiotherapy, Intensity-Modulated120178020.020 Why?
Medical Oncology1202222170.020 Why?
Cell Division1199845750.020 Why?
Amino Acids1201717270.020 Why?
Polymorphism, Single Nucleotide12010155000.020 Why?
Neoplasms, Experimental1201612800.020 Why?
Proteasome Endopeptidase Complex1201713310.020 Why?
Macaca fascicularis120129110.020 Why?
Niacinamide120124150.020 Why?
Lymphopenia120122860.020 Why?
DNA Mutational Analysis1201841820.020 Why?
Hydroxamic Acids120124950.020 Why?
Transfection1201758840.020 Why?
DNA Methylation1202242690.020 Why?
Biopsy1202067220.020 Why?
Cell Survival1199858770.020 Why?
United States32021695730.020 Why?
Lymphoma, Non-Hodgkin1199513770.020 Why?
Area Under Curve1201216550.020 Why?
Guidelines as Topic1201414070.020 Why?
Lung Neoplasms12012129850.020 Why?
Time Factors22021400500.020 Why?
Neutropenia120128880.020 Why?
Histone Deacetylase Inhibitors120127880.020 Why?
Sensitivity and Specificity12022147400.020 Why?
Kaplan-Meier Estimate1201765160.020 Why?
Disease Management1201724480.020 Why?
Early Detection of Cancer1202030510.020 Why?
Gene Expression Profiling1202293870.020 Why?
Immunotherapy1202143910.020 Why?
Health Personnel1201932030.020 Why?
Thalidomide120108780.020 Why?
Pyrimidines1201729180.020 Why?
Sex Factors12019103980.020 Why?
Age Factors12002183490.020 Why?
Predictive Value of Tests12021150360.020 Why?
Cell Movement1201752210.020 Why?
Fatigue1201215240.020 Why?
Protein Binding1201793750.020 Why?
Clinical Trials as Topic1202078970.020 Why?
Risk Factors22020719740.010 Why?
Longitudinal Studies12020138800.010 Why?
Multivariate Analysis12017122370.010 Why?
Enzyme Inhibitors1201438020.010 Why?
Incidence12021209130.010 Why?
Proportional Hazards Models12017123280.010 Why?
Logistic Models12017134020.010 Why?
Databases, Factual1201776900.010 Why?
Computer Simulation1201662370.010 Why?
Apoptosis1199897140.010 Why?
Cell Proliferation12017104550.010 Why?
Gene Expression Regulation, Neoplastic1201784000.010 Why?
Genetic Predisposition to Disease12020173840.010 Why?
Weekes's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (292)
Explore
_
Co-Authors (115)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.